Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections
Future Medicinal Chemistry · 03.06.2026 · 18 (11) · 1421-1441
DOI: 10.1080/17568919.2026.2658834 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 16.04.2026. Verfasst von Supriyo Saha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Drug Design, Small Molecule Libraries, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The emergence of infections caused by the gram-negative bacterium Pseudomonas aeruginosa is widely recognized as a major cause of nosocomial infections and antimicrobial resistance. In gram-negative bacteria such as P. aeruginosa, Lipid A helps maintain cell membrane integrity, and targeting its biosynthesis, known as the Raetz pathway, can be a strategic approach to control these infections. The set of Lpx enzymes involved in the synthesis of Lipid A serves as a potential target for inhibiton. This review outlines strategies for the design and development of small-molecule inhibitors of enzymes that inhibit bacterial growth and mitigate infection. In silico techniques and synthetic procedures have been employed to develop inhibitors targeting a specific enzyme. The presence of the UDP-GlcNAc group, acyl chain-binding group, five-membered ring, amide group, benzamide group, heteroatom, and fused rings is a key set of features that provides a basic scaffold for designing Lpx inhibitors. The structural characteristics of the receptor responsible for prominent ligand interactions have also been discussed, providing a foundation for the development of selective and potent inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
- Department of Zoology, Aligarh Muslim University, Aligarh, India.
ORCID-Profile: Supriyo Saha, Nikita Thapliyal, Muskan Singh, Shahnawaz Ali Bhat
Zitieren
APA
Saha, S., Thapliyal, N., Singh, M., & Ali Bhat, S. (2026). Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections. Future Medicinal Chemistry, 18(11), 1421-1441. https://doi.org/10.1080/17568919.2026.2658834
Vancouver
Saha S, Thapliyal N, Singh M, Ali Bhat S. Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections. Future Medicinal Chemistry. 2026;18(11):1421-1441. doi:10.1080/17568919.2026.2658834
BibTeX
@article{Saha2026,
author = {Saha, Supriyo and Thapliyal, Nikita and Singh, Muskan and Ali Bhat, Shahnawaz},
title = {Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {11},
pages = {1421--1441},
doi = {10.1080/17568919.2026.2658834}
}
EUVIMED